Her-2/neu overexpression is associated with thrombospondin-1-related angiogenesis and thrombospondin-1-unrelated lymphangiogenesis in breast cancer

Ming Chuan Hong, Cheng Yu Long, Yu Feng Tian, Ming Ping Wu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: Her-2/. neu overexpression is linked to poor prognosis and is a significant predictor of the response to trastuzumab (i.e., herceptin) therapy in breast cancer patients. Her-2/. neu promotes angiogenesis with thrombospondin-1 (TSP-1) as a mediator in breast cancer development and progression. However, the clinical quantitative evaluation of Her-2/. neu and specified localization of TSP-1 are currently lacking. Materials and methods: In this study, immunohistochemistry was performed to elucidate the invivo relationships between Her-2/. neu and TSP-1 expression, angiogenesis, and lymphangiogenesis in breast cancer. Based on immunohistochemical staining for anti-Her-2/. neu and related quantitative scoring of tumor cells, 28 individuals with high Her-2/. Neu expression (i.e., with a score of ≥2.0) were recruited into the study group. Another 28 individuals with low Her-2/. neu (i.e., with a score of

Original languageEnglish
Pages (from-to)114-121
Number of pages8
JournalGynecology and Minimally Invasive Therapy
Volume2
Issue number4
DOIs
Publication statusPublished - Nov 2013

Fingerprint

Lymphangiogenesis
Thrombospondin 1
Breast Neoplasms
Immunohistochemistry
Staining and Labeling
Neoplasms
Trastuzumab
Therapeutics

Keywords

  • Angiogenesis
  • Automated cellular imaging system
  • Breast cancer
  • Her-2/neu
  • Lymphangiogenesis
  • Thrombospondin-1
  • Tumor-stroma interaction

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Her-2/neu overexpression is associated with thrombospondin-1-related angiogenesis and thrombospondin-1-unrelated lymphangiogenesis in breast cancer. / Hong, Ming Chuan; Long, Cheng Yu; Tian, Yu Feng; Wu, Ming Ping.

In: Gynecology and Minimally Invasive Therapy, Vol. 2, No. 4, 11.2013, p. 114-121.

Research output: Contribution to journalArticle

@article{83cef356b82644e3bc309fb10c109a7e,
title = "Her-2/neu overexpression is associated with thrombospondin-1-related angiogenesis and thrombospondin-1-unrelated lymphangiogenesis in breast cancer",
abstract = "Introduction: Her-2/. neu overexpression is linked to poor prognosis and is a significant predictor of the response to trastuzumab (i.e., herceptin) therapy in breast cancer patients. Her-2/. neu promotes angiogenesis with thrombospondin-1 (TSP-1) as a mediator in breast cancer development and progression. However, the clinical quantitative evaluation of Her-2/. neu and specified localization of TSP-1 are currently lacking. Materials and methods: In this study, immunohistochemistry was performed to elucidate the invivo relationships between Her-2/. neu and TSP-1 expression, angiogenesis, and lymphangiogenesis in breast cancer. Based on immunohistochemical staining for anti-Her-2/. neu and related quantitative scoring of tumor cells, 28 individuals with high Her-2/. Neu expression (i.e., with a score of ≥2.0) were recruited into the study group. Another 28 individuals with low Her-2/. neu (i.e., with a score of",
keywords = "Angiogenesis, Automated cellular imaging system, Breast cancer, Her-2/neu, Lymphangiogenesis, Thrombospondin-1, Tumor-stroma interaction",
author = "Hong, {Ming Chuan} and Long, {Cheng Yu} and Tian, {Yu Feng} and Wu, {Ming Ping}",
year = "2013",
month = "11",
doi = "10.1016/j.gmit.2013.07.001",
language = "English",
volume = "2",
pages = "114--121",
journal = "Gynecology and Minimally Invasive Therapy",
issn = "2213-3070",
publisher = "Elsevier Taiwan LLC",
number = "4",

}

TY - JOUR

T1 - Her-2/neu overexpression is associated with thrombospondin-1-related angiogenesis and thrombospondin-1-unrelated lymphangiogenesis in breast cancer

AU - Hong, Ming Chuan

AU - Long, Cheng Yu

AU - Tian, Yu Feng

AU - Wu, Ming Ping

PY - 2013/11

Y1 - 2013/11

N2 - Introduction: Her-2/. neu overexpression is linked to poor prognosis and is a significant predictor of the response to trastuzumab (i.e., herceptin) therapy in breast cancer patients. Her-2/. neu promotes angiogenesis with thrombospondin-1 (TSP-1) as a mediator in breast cancer development and progression. However, the clinical quantitative evaluation of Her-2/. neu and specified localization of TSP-1 are currently lacking. Materials and methods: In this study, immunohistochemistry was performed to elucidate the invivo relationships between Her-2/. neu and TSP-1 expression, angiogenesis, and lymphangiogenesis in breast cancer. Based on immunohistochemical staining for anti-Her-2/. neu and related quantitative scoring of tumor cells, 28 individuals with high Her-2/. Neu expression (i.e., with a score of ≥2.0) were recruited into the study group. Another 28 individuals with low Her-2/. neu (i.e., with a score of

AB - Introduction: Her-2/. neu overexpression is linked to poor prognosis and is a significant predictor of the response to trastuzumab (i.e., herceptin) therapy in breast cancer patients. Her-2/. neu promotes angiogenesis with thrombospondin-1 (TSP-1) as a mediator in breast cancer development and progression. However, the clinical quantitative evaluation of Her-2/. neu and specified localization of TSP-1 are currently lacking. Materials and methods: In this study, immunohistochemistry was performed to elucidate the invivo relationships between Her-2/. neu and TSP-1 expression, angiogenesis, and lymphangiogenesis in breast cancer. Based on immunohistochemical staining for anti-Her-2/. neu and related quantitative scoring of tumor cells, 28 individuals with high Her-2/. Neu expression (i.e., with a score of ≥2.0) were recruited into the study group. Another 28 individuals with low Her-2/. neu (i.e., with a score of

KW - Angiogenesis

KW - Automated cellular imaging system

KW - Breast cancer

KW - Her-2/neu

KW - Lymphangiogenesis

KW - Thrombospondin-1

KW - Tumor-stroma interaction

UR - http://www.scopus.com/inward/record.url?scp=84901740677&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901740677&partnerID=8YFLogxK

U2 - 10.1016/j.gmit.2013.07.001

DO - 10.1016/j.gmit.2013.07.001

M3 - Article

VL - 2

SP - 114

EP - 121

JO - Gynecology and Minimally Invasive Therapy

JF - Gynecology and Minimally Invasive Therapy

SN - 2213-3070

IS - 4

ER -